 "Granules India bags exclusive rights for USpharma Windlas' four products")
Shares of Granules India jumped 8 per cent to Rs 265, also its new high, on the BSE on Friday after the company reported a strong set of numbers with Ebitda (earnings before interest, taxes, depreciation and amortization) margin improvement of 503 basis points to 25 per cent in June quarter (Q1FY21).
The company’s revenue from operations in Q1FY21 grew by 23.6 per cent year on year (YoY) to Rs 735.6 crore. Ebitda for the quarter grew at 54.8 per cent at Rs 183.60 crore. Profit after tax rose 33.9 per cent YoY at Rs 111.4 crore.
The
The company’s revenue from operations in Q1FY21 grew by 23.6 per cent year on year (YoY) to Rs 735.6 crore. Ebitda for the quarter grew at 54.8 per cent at Rs 183.60 crore. Profit after tax rose 33.9 per cent YoY at Rs 111.4 crore.
The
